from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1108c/xseA

LFCtreatmentdescriptionclass of inhibitor

0.219

Amikacinug/mL Amikacintranslation

1.023

Cap5-10ug/mL Capreomycintranslation

1.020

Rox10-50 ug/mL Roxithromycintranslation

0.416

SM2-5 ug/mL Streptomycintranslation

-0.003

Tet5-10 ug/mL Tetracyclinetranslation

-0.038

Rif0.2-5ug/mL Rifampicintranscription

0.301

Rifp0.1-0.5ug/mL Rifapentinetranscription

1.553

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.188

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.074

CPZ10-50 ug/mL Chlorpromazinerespiration

2.167

Clofazimine10-13 ug/mL Clofaziminerespiration

0.104

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.262

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.641

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.205

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.012

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.345

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.118

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.587

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.092

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.049

KCN5-20 ug/mL Potassium cyaniderespiration

-0.322

NaN30.2-2 mM Sodium aziderespiration

-0.161

Nigericin50 uM Nigericinrespiration

-0.317

TRC10-150 ug/mL Triclosanrespiration

0.870

TRZ10-25 ug/mL Thioridazinerespiration

-0.595

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.766

menadione6-10 ug/mL Menadionerespiration

0.178

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.286

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.336

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.751

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.587

NRP_1Non-replicating persistence stage 1dosRassociated

-0.327

Amp0.2mg/mL AmpicillincellWall

-1.216

Cephalexin20-100 ug/mL CephalexincellWall

-0.026

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.780

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.427

EMB10-20 ug/mL EthambutolcellWall

-1.029

Eta12-40 ug/mL EthionamidecellWall

-1.019

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.718

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.298

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.734

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.197

BZA0.12 mg/mL BenzamidearomaticAmides

0.267

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.332

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.635

H2O24 mM hydrogen peroxideDNAdamaging

0.568

Levo10 ug/mL LevofloxacinDNAdamaging

0.351

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.821

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.978

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.528

UVUV-irradiationDNAdamaging

0.598

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.564

Antimycin12.5-50 ug/mL Antimycin A?

-0.633

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.577

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.581

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.080

PA8240.2-2 ug/mL PA-824?

0.354

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

1.521

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.885

Verapamil50 uM Verapamil?

-0.454

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.515

methoxatin10-20 ug/mL Methoxatin?